NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Jan 3, 2023--

Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the first quarter of 2023 of $1.13 per share on the company’s common stock. The dividend is payable on March 7, 2023 to shareholders of record at the close of business on February 21, 2023. The ex-dividend date is February 17, 2023.

About Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005478/en/

CONTACT: Press Contacts:

media-relations@its.jnj.comInvestor Contacts:

RA-JJCUS-InvestorRel@ITS.JNJ.com

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Johnson & Johnson

Copyright Business Wire 2023.

PUB: 01/03/2023 08:55 AM/DISC: 01/03/2023 08:55 AM

http://www.businesswire.com/news/home/20230103005478/en